newsfilter
← Latest News
PR Newswire·

Phio Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

MARLBOROUGH, Mass., May 11, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune